Wisp
Telehealth service offering same-day prescription pickup or free home delivery for sexual and reproductive health needs.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$41.0m Valuation: $41.0m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Wisp operates in the telehealth sector, focusing on providing accessible and affordable sexual and reproductive healthcare services. The company serves individuals seeking discreet and judgment-free medical consultations and treatments, particularly for conditions related to sexual health. Wisp's business model involves online consultations with healthcare professionals, such as women's health nurse practitioners, and the subsequent prescription of medications that can be picked up the same day or delivered to the patient's home for free. The company generates revenue through consultation fees and the sale of prescribed medications. Wisp also offers at-home testing kits for STIs, fertility, and vaginal health, further broadening its service offerings. The market Wisp operates in includes individuals without insurance, those seeking privacy in their healthcare needs, and those looking for convenient and quick medical solutions. Wisp's affiliate program allows partners to earn commissions by promoting its services, thereby expanding its reach and customer base.
Keywords: telehealth, sexual health, reproductive health, online prescriptions, at-home testing, affordable care, discreet service, women's health, STI testing, affiliate program.